Literature DB >> 11999706

Poly(ADP-ribose) polymerase activation and cell injury in the course of rat heart heterotopic transplantation.

Claudia Fiorillo1, Stefania Pace, Vanessa Ponziani, Chiara Nediani, Avio Maria Perna, Piero Liguori, Cristina Cecchi, Niccolò Nassi, Gian Paolo Donzelli, Lucia Formigli, Paolo Nassi.   

Abstract

Free radicals and other reactive species generated during reperfusion of ischemic tissues may cause DNA damage and, consequently, the activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP). An excessive PARP activation may result in a depletion of intracellular NAD+ and ATP, hence cell suffering and, ultimately, cell death. The present study is aimed at clarifying the role of PARP in a heart transplantation procedure and the contribution of myocyte necrosis and/or apoptosis to this process. In our experimental model, rat heart subjected to heterotopic transplantation, low temperature global ischemia (2 h) was followed by an in vivo reperfusion (30 or 60 min). Under these conditions clear signs of oxidative stress, such as lipoperoxidation and DNA strand breaks, were evident. In addition to a marked activation, accompanied by a significant NAD+ and ATP depletion, PARP protein levels significantly increased after 60 min of reperfusion. Ultrastructural analysis showed nuclear clearings, intracellular oedema and plasma membrane discontinuity. Other relevant observations were the absence of typical signs of apoptosis like caspase-3 activation and PARP cleavage, random DNA fragmentation, rise in serum levels of heart damage markers. Our results suggest that during heart transplantation, the activation of PARP, causing energy depletion, results in myocardial cell injury whose dominant feature, at least in our experimental model, is necrosis rather than apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999706     DOI: 10.1080/10715760210168

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  6 in total

1.  Oxidative stress and inflammation: new molecular targets for cardiovascular diseases.

Authors:  Matteo Becatti; Amanda Mannucci; Niccolò Taddei; Claudia Fiorillo
Journal:  Intern Emerg Med       Date:  2018-06-01       Impact factor: 3.397

2.  Olaparib protects cardiomyocytes against oxidative stress and improves graft contractility during the early phase after heart transplantation in rats.

Authors:  Sevil Korkmaz-Icöz; Bartosz Szczesny; Michela Marcatti; Shiliang Li; Mihály Ruppert; Felix Lasitschka; Sivakkanan Loganathan; Csaba Szabó; Gábor Szabó
Journal:  Br J Pharmacol       Date:  2017-10-02       Impact factor: 8.739

3.  In vivo opening of the mitochondrial permeability transition pore in a rat model of ventricular fibrillation and closed-chest resuscitation.

Authors:  Iyad M Ayoub; Jeejabai Radhakrishnan; Raúl J Gazmuri
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 4.  Nitrosative stress and pharmacological modulation of heart failure.

Authors:  Pal Pacher; Richard Schulz; Lucas Liaudet; Csaba Szabó
Journal:  Trends Pharmacol Sci       Date:  2005-06       Impact factor: 14.819

Review 5.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

Review 6.  Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Cardiovasc Drug Rev       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.